{"nct_id":"NCT02752828","title":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2016-05-23","start_date_type":null,"primary_completion_date":"2018-03-12","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}